end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccretionExpense,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation,AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings,AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AmortizationOfDebtDiscountPremium,AmortizationOfFinancingCosts,AmortizationOfIntangibleAssets,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss,AvailableForSaleSecuritiesDebtSecurities,AvailableForSaleSecuritiesGrossRealizedGainLossNet,CapitalExpendituresIncurredButNotYetPaid,CashAcquiredFromAcquisition,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsFairValueDisclosure,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashDivestedFromDeconsolidation,CashEquivalentsAtCarryingValue,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest,ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest,ConstructionInProgressExpendituresIncurredButNotYetPaid,CostOfGoodsAndServicesSold,CostsAndExpenses,CurrentFederalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,DebtConversionConvertedInstrumentAmount1,DebtInstrumentCarryingAmount,DebtInstrumentInterestRateEffectivePercentage,DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction,DeconsolidationGainOrLossAmount,DeferredFederalIncomeTaxExpenseBenefit,DeferredForeignIncomeTaxExpenseBenefit,DeferredIncomeTaxLiabilities,DeferredTaxAssetsEquityMethodInvestments,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,DeferredTaxLiabilitiesFinancingArrangements,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DepreciationAndAmortization,DepreciationDepletionAndAmortization,DueFromRelatedPartiesCurrent,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EffectiveIncomeTaxRateReconciliationTaxExemptIncome,EmployeeBenefitsAndShareBasedCompensation,EmployeeRelatedLiabilitiesCurrent,FairValueAdjustmentOfWarrants,FairValueOfAssetsAcquired,FairValueOptionChangesInFairValueGainLoss1,FinanceLeaseInterestExpense,FinanceLeaseInterestPaymentOnLiability,FinanceLeaseLiability,FinanceLeaseLiabilityCurrent,FinanceLeaseLiabilityNoncurrent,FinanceLeaseLiabilityPaymentsDue,FinanceLeaseLiabilityPaymentsDueAfterYearFive,FinanceLeaseLiabilityPaymentsDueNextTwelveMonths,FinanceLeaseLiabilityPaymentsDueYearFive,FinanceLeaseLiabilityPaymentsDueYearFour,FinanceLeaseLiabilityPaymentsDueYearThree,FinanceLeaseLiabilityPaymentsDueYearTwo,FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear,FinanceLeaseLiabilityUndiscountedExcessAmount,FinanceLeasePrincipalPayments,FinanceLeaseWeightedAverageDiscountRatePercent,FiniteLivedIntangibleAssetsAccumulatedAmortization,FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths,FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo,FiniteLivedIntangibleAssetsGross,FiniteLivedIntangibleAssetsNet,GainLossOnSaleOfPropertyPlantEquipment,GeneralAndAdministrativeExpense,ImpairmentOfLongLivedAssetsHeldForUse,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,IncomeLossFromEquityMethodInvestments,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInDueFromRelatedParties,IncreaseDecreaseInEmployeeRelatedLiabilities,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IntangibleAssetsNetExcludingGoodwill,IntangibleAssetsNetIncludingGoodwill,InterestExpense,InterestExpenseDebt,InterestExpenseDebtExcludingAmortization,InterestPaidNet,InvestmentIncomeInterest,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures,LeaseAndRentalExpense,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebt,LongTermDebtCurrent,LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo,LongTermDebtNoncurrent,MarketableSecurities,MarketableSecuritiesCurrent,MarketableSecuritiesNoncurrent,MinorityInterest,MinorityInterestDecreaseFromRedemptions,MinorityInterestPeriodIncreaseDecrease,MoneyMarketFundsAtCarryingValue,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAttributableToNoncontrollingInterest,NetIncomeLossAttributableToNonredeemableNoncontrollingInterest,NetIncomeLossAvailableToCommonStockholdersBasic,NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance,NonoperatingIncomeExpense,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseImpairmentLoss,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFiveYears,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OperatingLeasesRentExpenseNet,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherLiabilitiesNoncurrent,OtherNoncashIncomeExpense,OtherNonoperatingExpense,OtherNonoperatingIncomeExpense,PaymentsForRepurchaseOfCommonStock,PaymentsForRepurchaseOfRedeemableNoncontrollingInterest,PaymentsForTenantImprovements,PaymentsOfCapitalDistribution,PaymentsOfDebtIssuanceCosts,PaymentsOfDividends,PaymentsOfFinancingCosts,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,PaymentsToAcquireEquityMethodInvestments,PaymentsToAcquireInProcessResearchAndDevelopment,PaymentsToAcquireIntangibleAssets,PaymentsToAcquireMarketableSecurities,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToMinorityShareholders,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,PrepaidExpenseCurrent,ProceedsFromConvertibleDebt,ProceedsFromDebtNetOfIssuanceCosts,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfDebt,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromMinorityShareholders,ProceedsFromPaymentsToMinorityShareholders,ProceedsFromRepaymentsOfRelatedPartyDebt,ProceedsFromRepaymentsOfSecuredDebt,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromSaleOfEquityMethodInvestments,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromStockOptionsExercised,ProceedsFromStockPlans,ProfitLoss,PropertyPlantAndEquipmentNet,RepaymentsOfLongTermDebt,ResearchAndDevelopmentExpense,ResearchAndDevelopmentInProcess,RestrictedCash,RestrictedCashCurrent,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SellingGeneralAndAdministrativeExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,StockholdersEquity,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueShareBasedCompensation,StockIssuedDuringPeriodValueStockOptionsExercised,StockRepurchasedDuringPeriodValue,TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense,TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests,TemporaryEquityNetIncome,TreasuryStockShares,TreasuryStockValue,TreasuryStockValueAcquiredCostMethod,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,ValuationAllowanceDeferredTaxAssetChangeInAmount,VariableLeaseCost,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AmortizationOfFinancingCostsAndDiscounts,DebtSecuritiesAvailableForSaleRealizedGainLoss,DeferredTaxLiabilitiesLeasingArrangements,DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities,EquitySecuritiesFvNi,EquitySecuritiesFvNiGainLoss,EquitySecuritiesFvNiRealizedGainLoss,EquitySecuritiesFvNiUnrealizedGain,EquitySecuritiesFvNiUnrealizedLoss,FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive,GainsLossesOnExtinguishmentOfDebt,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncreaseDecreaseInOperatingLeaseLiability,InterestPayableCurrent,PaymentsForProceedsFromOtherInvestingActivities,ProceedsFromPaymentsForOtherFinancingActivities,ReceivablesLongTermContractsOrPrograms,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions,WarrantsNotSettleableInCashFairValueDisclosure
2019-06-30,2019-08-14,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,,,,,,,,469426000.0,,,,,69000.0,2188000.0,,3358000.0,,,,,,,,,,,,,,,293803000.0,,294227000.0,,,,0.001,500000000.0,0.0,0.0,92000.0,-65964000.0,-8370000.0,-74334000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16987000.0,,,,-4956000.0,,,,,,,,,,,,1941000.0,,,,1662000.0,,,,,,,,,,,,,,,,,,,,,,,,,,48391000.0,,-658000.0,,,,,,-8370000.0,-7685000.0,-65964000.0,,-5016000.0,,69318000.0,-69318000.0,,,,,,,,,,,,,,,,,,,,,,,,,,219000.0,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,,,,,,,,,,,,,,,,,-74334000.0,,,52331000.0,,424000.0,,,-306593000.0,,,,,,,,,162925000.0,211316000.0,,,2119000.0,,,,,,,,,,,,,,,92893303.0,,,,,,,,,,,,,,,,,,,,,
2019-09-30,2019-11-08,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,10270000.0,,,,4789000.0,1570000.0,152000.0,826062000.0,,,,279000.0,,3953000.0,,5777000.0,,,,,640530000.0,558155000.0,175000.0,23000.0,554395000.0,,554547000.0,,,,413973000.0,356581000.0,414397000.0,,,356581000.0,0.001,500000000.0,117359502.0,117359502.0,117000.0,-59828000.0,-684000.0,-60512000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.51,,,,,,,,,7580000.0,,,276000.0,,,,,,,,,,,,,,,,,,,,,,,,,,23495000.0,,,,-6589000.0,,,,,,,,,,,,2113000.0,,,,2736000.0,907000.0,,,,,,,,,,,,116263000.0,640530000.0,39858000.0,,,,,,,75017000.0,,122080000.0,75886000.0,61939000.0,,166000.0,,,,,,-684000.0,-49000.0,-59980000.0,,-6132000.0,,81273000.0,-54532000.0,,,,,,,,,10477000.0,,1107000.0,1444000.0,2156000.0,2462000.0,2766000.0,542000.0,,,3219000.0,13352000.0,2598000.0,152000.0,1388000.0,,,-166000.0,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,22102000.0,8750000.0,,,,,,,,,,,,,,,-60664000.0,2984000.0,,55278000.0,,424000.0,,,-366573000.0,26741000.0,,,,,,,,459758000.0,521697000.0,,366237000.0,2120000.0,,,,2570000.0,,,,,,,,,,,117071188.0,,,,,,,,,,,,,,,,,,,,,
2019-12-31,2020-03-03,10-K,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,8852000.0,,,1509000.0,3020000.0,2222000.0,254000.0,848107000.0,,,,351000.0,,3937000.0,15198000.0,21374000.0,,,,10722263.0,631679000.0,568622000.0,254000.0,,520846000.0,,521100000.0,,,784000.0,363773000.0,307736000.0,364197000.0,-72048000.0,,307736000.0,0.001,500000000.0,123658287.0,123658287.0,124000.0,-260333000.0,-27998000.0,-288331000.0,8000000.0,,306800000.0,0.0,0.0,,75000000.0,,,,0.0,0.0,290000.0,7297000.0,129218000.0,290000.0,94335000.0,210000.0,18443000.0,1820000.0,1917000.0,128928000.0,,,290000.0,,859000.0,2845000.0,-2.48,0.21,-0.253,,-0.001,,0.041,0.014,0.0,13317000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94353000.0,0.0,-288585000.0,288585000.0,-20869000.0,,-4657000.0,,1462000.0,2845000.0,9270000.0,16929000.0,-65000.0,10647000.0,,,8765000.0,,,6092000.0,8915000.0,,2800000.0,,,,,,,,,,,155703000.0,631679000.0,60385000.0,95373000.0,,6748000.0,8861000.0,50939000.0,28825000.0,91791000.0,,182220000.0,31144000.0,65279000.0,,-1803000.0,,398792000.0,-217253000.0,-253587000.0,,-27998000.0,-25120000.0,-260587000.0,1206000.0,-22345000.0,1.0,306800000.0,-266240000.0,,,,8000000.0,,2000000.0,10000000.0,,11711000.0,2811000.0,1272000.0,1485000.0,1812000.0,2515000.0,1816000.0,,,,3020000.0,,26288000.0,254000.0,3527000.0,3547000.0,1210000.0,-1626000.0,,55011000.0,2097000.0,997000.0,,997000.0,,,,2500000.0,,212899000.0,2638000.0,55011000.0,0.001,25000000.0,0.0,0.0,19784000.0,,,36939000.0,366237000.0,,,23927000.0,,,179000.0,,,,1788000.0,921000.0,-288585000.0,5625000.0,,209947000.0,3560000.0,400000.0,,424000.0,-440031000.0,40560000.0,,,94353000.0,21374000.0,,,,408454000.0,473733000.0,921000.0,,10902000.0,16000.0,,,2243000.0,,0.0,,,7604000.0,0.0,0.0,3509000.0,79200000.0,,105099089.0,,,,,,0.0,,,,,,,,,,1716000.0,-818000.0,,,,
2020-03-31,2020-05-14,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,13086000.0,,,1761000.0,7465000.0,3145000.0,726000.0,986746000.0,,,167726000.0,,,8063000.0,8063000.0,10222000.0,,,,23130938.0,989799000.0,924957000.0,792000.0,66000.0,841525000.0,,842251000.0,0.0,,,757049000.0,,757473000.0,393276000.0,,,0.001,500000000.0,123774536.0,121359855.0,124000.0,-91378000.0,-12232000.0,-103610000.0,,,,,,,,,664000.0,,,,,,,,,,,,,,,,,,,,-0.78,,,,,,,,0.0,5647000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,34262000.0,,,,,0.0,4234000.0,,15000.0,-2845000.0,-7670000.0,734000.0,,-1000.0,,,4010000.0,,,2054000.0,1941000.0,,,853000.0,13473000.0,3798000.0,,1224000.0,1485000.0,1902000.0,2724000.0,2340000.0,2285000.0,537728000.0,989799000.0,64914000.0,,,,,,,92416000.0,,148126000.0,23210000.0,68303000.0,,-574000.0,,439173000.0,38023000.0,-83920000.0,,-12232000.0,-11366000.0,-91850000.0,26565000.0,-1595000.0,,102487000.0,-102487000.0,694000.0,,11188000.0,2510000.0,8678000.0,730000.0,8855000.0,541000.0,,,,,,,,,,0.0622,,,17022000.0,472000.0,2797000.0,-493000.0,,474000.0,75000000.0,,,,12375000.0,,,,,,,,4477000.0,,0.001,25000000.0,0.0,0.0,19782000.0,,550000000.0,,,,,24094000.0,,,,42500000.0,,,734000.0,,-104082000.0,15755000.0,,68225000.0,,424000.0,,424000.0,-531881000.0,,,9395000.0,,10222000.0,,,,380715000.0,449018000.0,,,529000.0,,75000000.0,,3053000.0,,2414681.0,75000000.0,75000000.0,,,,,,159000.0,117803438.0,,,,,,,,,,,,,,,,,,,,,
2020-06-30,2020-08-11,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,12835000.0,,,,11462000.0,8609000.0,858000.0,992691000.0,,,,,,7295000.0,7295000.0,18392000.0,5574000.0,289000.0,,,905227000.0,861935000.0,860000.0,2000.0,742549000.0,,743407000.0,,,,540919000.0,443387000.0,541343000.0,,,443387000.0,0.001,500000000.0,124665939.0,122251258.0,125000.0,-120902000.0,-15180000.0,-136082000.0,,,124567000.0,,,,,0.088,,,,,,,,,,,,,,,,,,,,,-1.03,,,,,,,,,13590000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37969000.0,,,,,0.0,,,,,,,,,,,10754000.0,10217000.0,4354000.0,,934000.0,,,1137000.0,14941000.0,3798000.0,,1224000.0,1485000.0,2399000.0,3895000.0,2140000.0,2197000.0,577715000.0,905227000.0,92640000.0,,,,,,,92908000.0,,300020000.0,,59847000.0,,-431000.0,,,,,,-15180000.0,-13602000.0,-121034000.0,3537000.0,-11647000.0,,124567000.0,-124567000.0,995000.0,,12744000.0,3627000.0,9117000.0,1700000.0,10465000.0,,,,,,,,,,,0.0587,,,17254000.0,132000.0,9399000.0,,,-1827000.0,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,20996000.0,,,,,,,,,,,,,,,,-136214000.0,15573000.0,,86598000.0,,424000.0,,424000.0,-652915000.0,,,,37969000.0,,,,,265759000.0,325606000.0,,,,,,,1906000.0,,2414681.0,75000000.0,,,,,,,142000.0,117012062.0,,,,,,,,,,,,,,,,,,,,,
2020-09-30,2020-11-05,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,9839000.0,,,,8691000.0,4706000.0,461000.0,1006944000.0,,,,,,11748000.0,11748000.0,17699000.0,,,,,787693000.0,745384000.0,462000.0,1000.0,608927000.0,,609388000.0,,,,366967000.0,,367391000.0,,,,0.001,500000000.0,124957091.0,122542410.0,125000.0,-116256000.0,-14308000.0,-130564000.0,,0.0,128066000.0,,,,,0.088,,,,,,,,,,,,,,,,,,,,8000000.0,-0.98,,,,,,,,,18755000.0,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,36016000.0,,,,,0.0,,,,,,,,,,,10929000.0,,,,692000.0,,,1252000.0,13876000.0,,3895000.0,,1224000.0,1485000.0,2399000.0,1075000.0,2023000.0,569306000.0,787693000.0,75707000.0,,,,,,,93392000.0,,343714000.0,,52057000.0,,-799000.0,,,,,,-14308000.0,-13177000.0,-115859000.0,7267000.0,-10228000.0,,128066000.0,-119939000.0,995000.0,,11853000.0,3617000.0,8236000.0,1100000.0,9644000.0,,,,,,,,,,,0.0591,,,16483000.0,-397000.0,13469000.0,,,9000.0,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,26703000.0,,,,,,,,,,,,,,,,-130167000.0,16182000.0,,92050000.0,,424000.0,,424000.0,-768774000.0,8127000.0,,,36016000.0,,,,,163756000.0,215813000.0,,,,,,,2574000.0,,2414681.0,75000000.0,,,,,,,257000.0,118168063.0,,,,,,,,,,,,,,,,,,,,,
2020-12-31,2021-02-25,10-K,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,8945000.0,,,17737000.0,,5579000.0,192000.0,1021344000.0,,,168078000.0,,,,36530000.0,58459000.0,,,,29240319.0,703588000.0,642824000.0,196000.0,4000.0,517256000.0,,517448000.0,0.0,1101000.0,,356082000.0,,358679000.0,-5518000.0,,,0.001,500000000.0,125264070.0,122849389.0,125000.0,-448786000.0,-56764000.0,-505550000.0,,,482731000.0,0.0,0.0,,92500000.0,,,,0.0,0.0,36673000.0,7608000.0,260030000.0,35578000.0,191308000.0,613000.0,37964000.0,5471000.0,5707000.0,224452000.0,1095000.0,32938000.0,221000.0,,1456000.0,,-3.8,0.21,-0.25,,-0.003,0.01,0.033,,,29682000.0,-3338000.0,,,9000.0,34000.0,1701000.0,128000.0,1573000.0,2031000.0,37000.0,238000.0,459000.0,445000.0,432000.0,420000.0,,330000.0,25000.0,0.0662,,,,,,,,,,145684000.0,0.0,-505488000.0,505488000.0,,,-735000.0,,8335000.0,-2845000.0,8589000.0,2146000.0,,7059000.0,0.0,,36655000.0,,,15322000.0,4015000.0,,,4627000.0,21819000.0,2608000.0,4825000.0,3430000.0,3231000.0,3434000.0,4291000.0,,3347000.0,595702000.0,703588000.0,95648000.0,93879000.0,1458000.0,,,,,92421000.0,,251011000.0,,48350000.0,,-1843000.0,,447189000.0,-52993000.0,-399714000.0,,-56764000.0,,-448724000.0,50828000.0,-31006000.0,1.0,482731000.0,-474482000.0,3786000.0,,18472000.0,3795000.0,14677000.0,4169000.0,16508000.0,3088000.0,,,,,,,,,,0.0624,13349000.0,,23931000.0,-62000.0,9520000.0,-1225000.0,,1634000.0,75000000.0,,,,13039000.0,,,714000.0,,,,287852000.0,7518000.0,5000000.0,0.001,25000000.0,0.0,0.0,35731000.0,,550000000.0,,,,,24094000.0,,,,249137000.0,,147000.0,12923000.0,1205000.0,-505488000.0,20325000.0,,337047000.0,4727000.0,2600000.0,139000.0,2458000.0,-888755000.0,8249000.0,1726000.0,19595000.0,145684000.0,58459000.0,,,,57906000.0,106256000.0,,,1205000.0,,,,1630000.0,,2414681.0,75000000.0,75000000.0,12524000.0,0.0,0.0,5144000.0,95500000.0,832000.0,117995457.0,,,3514000.0,,,0.0,,,,,,,,-3472000.0,600000.0,6760000.0,,,224000.0,,
2021-03-31,2021-05-06,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,10340000.0,,,1249000.0,,4518000.0,-57000.0,767117000.0,,,,,,,19841000.0,34896000.0,,,,39386919.0,1093308000.0,945114000.0,67000.0,124000.0,863324000.0,,863267000.0,0.0,1787000.0,,471176000.0,,473774000.0,115095000.0,,,0.001,500000000.0,152289274.0,149114600.0,152000.0,-163328000.0,-8003000.0,-171331000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,462000.0,-1.18,,,,,,,,,20741000.0,,,,28000.0,36000.0,1694000.0,200000.0,1494000.0,1996000.0,,420000.0,,459000.0,445000.0,432000.0,202000.0,302000.0,,0.0662,,,,,,,,,,45407000.0,,,,,0.0,1792000.0,,-3540000.0,462000.0,-12981000.0,6113000.0,,-1448000.0,,,9738000.0,,,8913000.0,394000.0,,,2173000.0,20759000.0,,4344000.0,,3487000.0,3282000.0,3488000.0,3536000.0,3090000.0,1481402000.0,1093308000.0,94729000.0,,3646000.0,,,,,90762000.0,,447942000.0,82202000.0,5929000.0,-91997000.0,-517000.0,,547912000.0,-282052000.0,-150765000.0,,-8003000.0,,-163079000.0,,-3578000.0,,167966000.0,-167504000.0,1365000.0,2600000.0,17669000.0,3807000.0,13862000.0,1470000.0,12997000.0,1365000.0,,,,,,,,,,0.0627,18254000.0,,30179000.0,-249000.0,11612000.0,-5096000.0,,5766000.0,50000000.0,,,,16064000.0,,,1021000.0,,,,379291000.0,1961000.0,,0.001,25000000.0,0.0,0.0,25534000.0,,747500000.0,,,,,,,,,99200000.0,,,7464000.0,1652000.0,-171082000.0,22816000.0,,122559000.0,,,139000.0,2459000.0,-1037506000.0,462000.0,,133000.0,,33577000.0,,,,-395294000.0,-389365000.0,,,,,,,1271000.0,,3174674.0,125000000.0,50000000.0,,,,,,751000.0,138627729.0,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-05,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,22329000.0,1213000.0,,,,6378000.0,36000.0,799679000.0,,,,,,,32509000.0,32035000.0,843000.0,24000.0,,,1081486000.0,909871000.0,60000.0,24000.0,775558000.0,,775594000.0,,,,378420000.0,,381128000.0,,,,0.001,500000000.0,152894108.0,149614740.0,153000.0,-96255000.0,-5726000.0,-101981000.0,,109000.0,148039000.0,,,,,,,,,,,,,,,,,,,,,,,,,8962000.0,-0.66,,,,,,,,,21865000.0,,,,28000.0,,1670000.0,258000.0,1412000.0,1945000.0,,420000.0,,459000.0,445000.0,432000.0,151000.0,275000.0,,0.0662,,1500000.0,900000.0,1500000.0,1500000.0,1500000.0,,,,,,,,,0.0,,,,,,,,,,20000000.0,10839000.0,8509000.0,7642000.0,,323000.0,,,2341000.0,26840000.0,,5360000.0,,3980000.0,4011000.0,4287000.0,2783000.0,4278000.0,1537111000.0,1081486000.0,131909000.0,,,,,,,102611000.0,,459243000.0,60688000.0,6804000.0,,3618000.0,,,,,,-5726000.0,,-96348000.0,,-8059000.0,,,-94015000.0,1256000.0,,22562000.0,4540000.0,18022000.0,,15964000.0,,,,,,,,,,,0.0579,21177000.0,,49797000.0,93000.0,13265000.0,,,2457000.0,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,26670000.0,,,,,,,,,,,,,,,,-102074000.0,26272000.0,,101960000.0,,,176000.0,2532000.0,-1133854000.0,54024000.0,,,45970000.0,,,,,-464294000.0,-457490000.0,,,,,,,1865000.0,,3279368.0,130308000.0,5308000.0,,,,,,969000.0,146754299.0,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-04,10-Q,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,12035000.0,,,,,4976000.0,19000.0,821220000.0,734000.0,,,,,,16896000.0,16130000.0,848000.0,23000.0,700000.0,,781524000.0,639710000.0,47000.0,28000.0,488889000.0,0.0,488908000.0,,,,180347000.0,,183079000.0,,,,0.001,500000000.0,153279652.0,147087891.0,153000.0,-155952000.0,-5081000.0,-161033000.0,,1454000.0,151843000.0,,,,,,,,,,,,,,,,,,,,,,,,,462000.0,-1.06,,,,,,,,,21560000.0,,,,27000.0,,1612000.0,283000.0,1329000.0,1860000.0,,420000.0,,459000.0,445000.0,432000.0,66000.0,248000.0,,0.0662,1296000.0,3700000.0,1200000.0,3700000.0,3700000.0,3700000.0,47500000.0,46204000.0,,,,,,,0.0,,,,,,,,,46204000.0,,11067000.0,8514000.0,7643000.0,,234000.0,,,2683000.0,27720000.0,,6455000.0,,3967000.0,4478000.0,5289000.0,1214000.0,4038000.0,1517398000.0,781524000.0,95823000.0,,,,,,,103138000.0,,419264000.0,,4556000.0,,362000.0,,,,,,-5081000.0,,-155935000.0,,-11517000.0,,,-149499000.0,,,23682000.0,4999000.0,18683000.0,,17108000.0,,,,,,,,,,,0.0558,14608000.0,,33054000.0,-17000.0,27578000.0,,,-684000.0,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,31927000.0,,,,,,,,,,,,,,,,-161016000.0,27741000.0,,104305000.0,,,176000.0,2556000.0,-1289789000.0,2344000.0,,,46084000.0,,,,,-743397000.0,-738841000.0,,,,,,,2967000.0,,6191761.0,275000000.0,144692000.0,,,,,,1111000.0,146662756.0,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-02-25,10-K,"BridgeBio Pharma, Inc.",BBIO,CIK0001743881,USD,11884000.0,,,5795000.0,,6786000.0,-132000.0,841530000.0,,,,,,,89823000.0,105574000.0,,,2600000.0,52252566.0,1012792000.0,888858000.0,2000.0,134000.0,626976000.0,,626844000.0,,563000.0,,393772000.0,233101000.0,396365000.0,37686000.0,,233103000.0,0.001,500000000.0,153535084.0,147343323.0,154000.0,-562863000.0,-23915000.0,-586778000.0,,2735000.0,646348000.0,0.0,0.0,,,,1120000.0,,0.0,0.0,8257000.0,,432166000.0,8257000.0,331537000.0,448000.0,67724000.0,10233000.0,8833000.0,423909000.0,,,339000.0,3300000.0,5843000.0,,-3.9,0.21,-0.256,,-0.005,0.012,0.039,,,37041000.0,1197000.0,,,402000.0,272000.0,1540000.0,295000.0,1245000.0,1761000.0,0.0,387000.0,38000.0,459000.0,445000.0,432000.0,,221000.0,,0.0662,2566000.0,3700000.0,,3700000.0,3700000.0,3700000.0,47500000.0,44934000.0,,,,-586478000.0,,,,2833000.0,,12007000.0,,7378000.0,9816000.0,,4262000.0,44934000.0,,46778000.0,32643000.0,29307000.0,29774000.0,1133000.0,,,10256000.0,26095000.0,4413000.0,6035000.0,1903000.0,3971000.0,4481000.0,5292000.0,,3729000.0,1878371000.0,1012792000.0,135069000.0,,,,,,,430752000.0,,393743000.0,,3412000.0,-91997000.0,3455000.0,,736446000.0,-200826000.0,-497934000.0,,-23915000.0,,-562539000.0,,-9822000.0,1.0,,-576632000.0,5611000.0,2600000.0,22366000.0,4938000.0,17428000.0,6122000.0,15907000.0,,,,,,,,,,,0.0558,30282000.0,,33027000.0,-324000.0,22069000.0,-7092000.0,,35823000.0,200000000.0,,2449000.0,,16064000.0,,,4746000.0,53383000.0,,35000000.0,589892000.0,13246000.0,,0.001,25000000.0,0.0,0.0,32446000.0,,747500000.0,456296000.0,,,,,,,,380200000.0,34150000.0,,16643000.0,3821000.0,-586454000.0,30066000.0,124119000.0,451024000.0,,2600000.0,177000.0,2416000.0,-1436966000.0,69716000.0,,6380000.0,192210000.0,99505000.0,,,,-870414000.0,-867002000.0,,,,,,,1423000.0,,6191761.0,275000000.0,200000000.0,21254000.0,,0.0,5047000.0,199500000.0,4243000.0,144356619.0,3336000.0,0.0,2844000.0,5074000.0,49148000.0,29914000.0,2206000.0,68538000.0,40830000.0,26100000.0,3700000.0,-3337000.0,24000.0,-6122000.0,,,,19749000.0,354000.0,4037000.0,2100000.0
